Track DND Technologies, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

DND Technologies, Inc. DNDT · Stock Open DND Technologies, Inc. in new tab

0.1555 USD
EPS
-3.91
ROE
-388.39
Beta
-1.44
Loading chart...
Key Metrics
EPS-3.91
Debt/Equity522.66

DCF Valuation

Tweak assumptions to recompute fair value for DND Technologies, Inc. (DNDT)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

DND Technologies, Inc. Logo DND Technologies, Inc. Analysis (DNDT)

United States Financials Official Website Stock

Is DND Technologies, Inc. a good investment? DND Technologies, Inc. (DNDT) is currently trading at 0.1555 USD.

Investor FAQ

Does DND Technologies, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is DND Technologies, Inc.?

DND Technologies, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

DND Technologies, Inc., a holding company, produces and sells various specialty balms. It also manufactures and distributes pharmaceutical products, including Bioassaygen Gel to reduce wrinkles and promote natural skin re-genesis; Bioassaygen Cosmetic Mask for vanity applications; Bioassaygen Bio-Skin, a skin replacement bandage; and Bioassaygen Delivery Gel that accelerates natural skin re-genesis. The company distributes its products through wholesale, retail, and Internet. DND Technologies, Inc. was founded in 1997 and is based in New York, New York.

Exchange Ticker
PNK (United States) DNDT
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion